Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
CHATHAM, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated […]
ACV to Participate in the 4th Annual Needham Consumer Tech / Ecommerce Virtual Conference
BUFFALO, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) — ACV (Nasdaq: ACVA), a leading digital automotive marketplace and data services partner […]
Credit Acceptance Named a 2024 Top Workplace in Michigan by the Detroit Free Press
Southfield, Michigan, Nov. 18, 2024 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, […]
ARRAY Announces $3 Million Investment in Swap Robotics to Drive Automation in PV Installation
ALBUQUERQUE, N.M., Nov. 18, 2024 (GLOBE NEWSWIRE) — ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a global leader in […]
Rent the Runway to Report Third Quarter 2024 Results on December 9, 2024
NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) — Rent the Runway, Inc. (“Rent the Runway”) (Nasdaq: RENT) announced today that […]
Symbotic Reports Fourth Quarter and Fiscal Year 2024 Results
WILMINGTON, Mass., Nov. 18, 2024 (GLOBE NEWSWIRE) — Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the […]
The Herzfeld Caribbean Basin Fund, Inc. Announces Preliminary Tender Offer Results
MIAMI, Nov. 18, 2024 (GLOBE NEWSWIRE) — Thomas J. Herzfeld Advisors, Inc., an SEC-registered investment adviser, and The Herzfeld Caribbean […]
GOGL – Invitation to presentation of Q3 2024 Results
Golden Ocean Group Limited (the “Company”) will publish its financial results for the third quarter of 2024 on Wednesday November […]
Verizon statement on naming of Brendan Carr as FCC Chairman
NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) — The following should be attributed to Hans Vestberg, Verizon, chairman and CEO: […]
NewAmsterdam Pharma Presents Additional Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia at AHA Scientific Sessions 2024
– Met primary endpoint with LDL-C mean reduction versus placebo of 36.3% at day 84 and 41.5% at day 365 […]
